Litcius/Paper detail

Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China

Xiangyu Zhang, Liang Zeng, Yizhi Li, Qinqin Xu, Haiyan Yang, Analyn Lizaso, Xinru Mao, Renan Jin, Yu Zeng, Qinglin Li, Jianbo Wang, Li Yang, Yongchang Zhang, Nong Yang

2021Cancer Immunology Immunotherapy64 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineLung cancerOncologyChemotherapyCombination therapyBlockadeRetrospective cohort studyProportional hazards modelCancerPerformance statusGastroenterologyReceptorLung Cancer Research StudiesCancer Immunotherapy and BiomarkersPeptidase Inhibition and Analysis
Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China | Litcius